Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129629) titled 'Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Condition:
Tuberculosis, Pulmonary
Drug-Susceptible Pulmonary Tuberculosis
Intervention:
Drug: Bedaquiline (B)
Drug: Moxifloxacin
Drug: Pyrazinamide (PZA)
Drug: Delamanid (D)
Drug: Isoniazid (H)
Drug: Rifampicin (R)
Recruitment Status: Not recrui...